Beyond women's health: The new discipline of gender-specific medicine

Medical Clinics of North America

Volumn 87, Issue 5, 2003, Pages 917-937

  Legato, Marianne J ^a,b  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

BONE; BRAIN; CARDIOVASCULAR SYSTEM; FEMALE; GENDER; GOVERNMENT; HEALTH; HEALTH CARE POLICY; HUMAN; IMMUNE SYSTEM; LUNG; MEDICAL RESEARCH; ORGANIZATION; PAIN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0242333141     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00063-4     Document Type: Review

References (68)

1. Morantz-Sanchez RM. Sympathy and science: Women physicians in American medicine. New York: Oxford University Press; 1985.
2. Newcomb HP, Ackerman CA. Acting senior: case report: 1884. Carcinoma of the stomach. J Gend Specif Med 2000;3:38.
3. The National Commission for the Protection of Human Subjects of Biomedical Behavioral Research. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. 1979;April:18. Department of Health, Education and Welfare. Washington, DC. US Government Printing Office.
4. Mastroianni AC, Faden R, Federman D. Women and health research: ethical and legal issues of including women in clinical studies, vol. 1. Washington: National Academy Press; 1994.
5. Prescott S. Why researchers don't study women: the responses of 62 researchers. Sex Roles 1978;4:899-905.
6. Food, Drug and Cosmetic Act Amendments 21USC § 355 (1962).
7. U.S. Public Health Service. Women's health: report of the Public Health Service Task Force on Women's Health Issues, vol. 1, No. 1. 1985. DHHS Pub No. 85-50206. Washington, DC. US Government Printing Office.
8. Nadel MV. National Institutes of Health: problems in implementing policy on women in study populations. Washington: US General Accounting Office; 1990.
9. US Department of Health and Human Services. National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. 59 Federal Register 14508 (1994).
10. General Accounting Office. Women's health: FDA needs to ensure more study of gender differences in prescription drug testing. 29 October 1992. Washington, DC. US General Accounting Office. GAO-HRD-93-17.
11. France N. Gender and health: a technical paper.
12. Bird CE. Women and health research, vol. 2. Workshop and commissioned papers. Washington: National Academy Press; 1994.
13. Wizemann TM, Pardu M. Exploring the biological contributions to human health. Does sex matter? Washington: National Academy Press; 2001.
14. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997;278:675-80.
15. Rappold GA. The pseudoautosomal regions of the human sex chromosomes. Hum Genet 1993;92:315-24.
16. Pinsky L, Erickson RP, Schimke RN. Genetic disorders of human sexual development. Oxford: Oxford University Press; 1999.
17. Legato MJ. Textbook of gender-specific medicine. New York Academic Press, in press.
18. Legato MJ. Gender-specific aspects of human biology for the practicing physician. Armonk, NY: Futura Publishing Company; 1997.
19. Gordon CL, Halton JM, Atkinson SA, Webber CE. The contributions of growth and puberty to peak bone mass. Growth Dev Aging 1991;55:257-62.
20. Eriksen EF, Mosekilde L, Melson F. Trabecular bone resorption depth decreases with age: differences between normal males and females. Bone 1985;6:141-6.
21. Riggs BL, Melton LJ. Medical progress: involutional osteoporosis. N Engl J Med 1986;314:1676-86.
22. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-70.
23. Burke J, Goldberger J, Ehlert FA, et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996;100:537-43.
24. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1991;8:690-5.
25. Burke J, Goldberger J, Ehlert FA, et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996;100:537-43.
26. Larsen J, Tung R, Sadananada R, et al. Effects of hormonal replacement on QT interval [abstract]. J Am Coll Cardiol 1998;31:264.
27. Hara M, Danilo P Jr, Rosen MR. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. Pharmacol Exp Ther 1998;285:1068-72.
28. Ebert SN, Xiao Ke L, Woosley RL. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health 1998;7:547-57.
29. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-50.
30. Babiker FA, DeWindt LJ, van Eickels M, et al. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 2002;53:709-19.
31. Rosenkranz-Weiss P, Tomek RJ, Mathew J, et al. Gender-specific differences in expression of mRNA's for functional and structural proteins in the rat ventricular myocardium. J Mol Cell Cardiol 1994;26:261-70.
32. Klein LE, Sigel AV, Douglas JA, et al. Upregulation of collagen type I gene expression in the ventricular myocardium of thyroidectomized male and female rats. J Mol Cell Cardiol 1996;28:33-42.
33. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993;72:310-3.
34. Koren MJ, Devereaux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.
35. Goy RW, McEwen BS. Sexual differentiation of the brain. Cambridge, MA: MIT Press; 1980.
36. Swaab DR, Hoffman MA. Sexual differentiation of the human brain: an historical perspective. Prog Brain Res 1984;61:361-74.
37. Kelly DD. Sexual differentiation of the nervous system. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neuranal science. 3rd edition. New York: Elsevier; 1991;1131-148.
38. Shaywitz BA, Shawitz SE, Pugh HR, et al. Sex differences in the functional organization of the brain for language. Nature 1995;375:607-69.
39. Canli T, Desmond JEW, Zhao Z, Gabrieli JD. Sex differences in the neural basis of emotional memories. Proc Natl Acad Sci U S A 2002;99:10789-94.
40. Linn MC, Petersen AC. Emergence and characterization of sex differences in spatial ability: a meta-analysis. Child Dev 1985;56:1479-98.
41. Robert M, Tanguay M. Perception and representation of the Euclidean coordinates in mature and elderly men and women. Exp Aging Res 1990;16:123-31.
42. Halbreich U, Lumley LA. The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 1993;29:159-73.
43. Best NR, Rees MP, Barlow DH, Cowen PH. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 1992;17:87-93.
44. Biegon A, Reches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983;32:2015-21.
45. Giamberardino MA, Berkley KJ, Iezzi S, deBigontina P, Vecchiet L. Pain threshold variations in somatic wall tissues as a function of menstrual cycle, segmental site and tissue depth in non-dysmenorrheic women, dysmenorrheic women and men. Pain 1997;71:187-97.
46. Affleck G, Tennen H, Keefe FJ, Lefebvre JC, Kashikar-Zuch S, Right K, et al. Everyday life with osteoarthritis or rheumatoid arthritis: independent effects of disease and gender on daily pain, mood and coping. Pain 1999;83:601-9.
47. Unruh AM, Ritchie J, Merskey H. Does gender affect appraisal of pain and pain coping strategies? Clin J Pain 1999;15:31-40.
48. Fillingim RB. Sex gender and pain. Progress in pain research and management, Vol. 17. Seattle, WA: International Association for the Study of Pain Press; 2000.
49. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 1996;2:1248-50.
50. Slocumb JC. Acute and chronic pelvic visceral pain. The International Pelvic Pain Society. Available at: www.pelvipain.org/acute_chronic_visc.asp. Accessed 2002.
51. Giamberardino MA. Sex-related and hormonal modulation of visceral pain. In: Fillingim RB, editor. Sex, gender and Pain. Progress in pain research and management. Seattle, WA: International Association for the Study of Pain Press; 2000. p. 135-63.
52. Correale J, Airas M, Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein specific CD4 and T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998;161:3365-74.
53. Rosenbaum M, Hirsch J, Heymsfield SB, Gallagher D, Chu F. Effects of gender, body composition and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-7.
54. Inman RD. Immunologic sex differences and the female preponderance in systemic lupus erythematosus. Arthritis Rheum 1982;25:618-23.
55. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1997;40:797-803.
56. Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 2000;91:22-8.
57. White DP, Douglas NJ, Pickett CK, Wel JV, Zwillich CW. Sexual influence on the control of breathing. J Appl Physiol 1983;54:874-9.
58. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-state lung cancer in women. J Natl Cancer Inst 1999;91:2032-8.
59. Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Gaiter Davis AL, Luketich JD, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000;92:24-33.
60. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88:183-92.
61. Waxman DJ. Interactions of hepatic cytochrome P-450 with steroid hormones: regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Pharmacol 1988;37:71-84.
62. Kato R, Kamataki T. Cytochrome P-450 as a determinant of sex differences of drug metabolism in the rat. Zenobiotica 1982;12:787-800.
63. Harada N, Negishi M. Mouse liver testosterone 15 alpha hydroxylase (cytochrome P-450): purification, regioselectivity, stereospecificity and sex = dependent expression. J Biol Chem 1984;259:1256-71.
64. Fujita S, Chiba M, Ohta M, Kitani K, Suzuki T. Alteration of plasma sex hormone levels associated with old age and its effect of hepatic drug metabolism in rats. J Pharmacol Exp Ther 1990;253:369-74.
65. Back DJ, Orme ML'E. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet 1990;18:472-84.
66. Skett P, Joels LA. Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rat. Biochem Pharmacol 1985;34:287-9.
67. Tannenbaum GS. Growth hormone secretory dynamics in streptozotocin diabetes: evidence for role of endogenous circulating somatostatin. Endocrinology 1981;108:72-82.
68. Barr J, Skett P. The role of cytochrome P-450, NADPH-cytochrome P-450 reductase and lipids in sex differences in hepatic drug metabolism. Br J Pharmacol 1984;83:396.